The drug treatment deadlock in psychiatry and the route forward.
作者信息
Howes Oliver D, Baxter Luke
机构信息
Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
出版信息
World Psychiatry. 2023 Feb;22(1):2-3. doi: 10.1002/wps.21059.
Abstract
摘要
相似文献
1
The drug treatment deadlock in psychiatry and the route forward.精神病学中的药物治疗僵局及前进方向。
World Psychiatry. 2023 Feb;22(1):2-3. doi: 10.1002/wps.21059.
2
[Shared feeling of therapeutic deadlock in a psychiatric institution].
Soins Psychiatr. 2016 Jul-Aug;37(305):16-20. doi: 10.1016/j.spsy.2016.05.001.
3
Deadlock-free genetic scheduling algorithm for automated manufacturing systems based on deadlock control policy.基于死锁控制策略的自动化制造系统无死锁遗传调度算法
IEEE Trans Syst Man Cybern B Cybern. 2012 Jun;42(3):603-15. doi: 10.1109/TSMCB.2011.2170678. Epub 2011 Nov 16.
4
A novel resource management technique for deadlock-free systems.一种用于无死锁系统的新型资源管理技术。
Int J Inf Technol. 2022;14(2):627-635. doi: 10.1007/s41870-021-00670-6. Epub 2021 May 10.
5
Deadlock, a novel protein of Drosophila, is required for germline maintenance, fusome morphogenesis and axial patterning in oogenesis and associates with centrosomes in the early embryo.Deadlock是果蝇的一种新型蛋白质，在卵子发生过程中，对于生殖系维持、纺锤体形态发生和轴向模式形成是必需的，并且在早期胚胎中与中心体相关联。
Dev Biol. 2006 Jun 15;294(2):406-17. doi: 10.1016/j.ydbio.2006.03.002. Epub 2006 Apr 17.
6
Spontaneous deadlock breaking on amoeba-based neurocomputer.基于变形虫的神经计算机上的自发死锁打破
Biosystems. 2008 Jan;91(1):83-93. doi: 10.1016/j.biosystems.2007.08.004. Epub 2007 Aug 19.
7
Avoidance versus detection and recovery problem in buffer-space allocation of flexibly automated production systems.
IEEE Trans Syst Man Cybern B Cybern. 2000;30(5):799-811. doi: 10.1109/3477.875453.
8
Comparing digraph and Petri net approaches to deadlock avoidance in FMS.比较用于柔性制造系统中死锁避免的有向图和Petri网方法。
IEEE Trans Syst Man Cybern B Cybern. 2000;30(5):783-98. doi: 10.1109/3477.875452.
9
P systems with deadlock.
Biosystems. 2003 Jul;70(2):95-105. doi: 10.1016/s0303-2647(03)00033-9.
10
On a maximally permissive deadlock prevention policy for automated manufacturing systems by using resource-oriented Petri nets.关于使用面向资源的Petri网对自动化制造系统采用最大许可死锁预防策略的研究
ISA Trans. 2019 Jun;89:67-76. doi: 10.1016/j.isatra.2018.11.025. Epub 2018 Dec 19.
引用本文的文献
1
Effect of , , and Variation on Antipsychotic Treatment Outcomes.[具体基因名称1]、[具体基因名称2]和[具体基因名称3]变异对抗精神病药物治疗结果的影响。 （你原文中三个“,”处应该是具体基因名称等内容，这里只是按格式补充完整以便理解）
Pharmaceuticals (Basel). 2025 Jun 14;18(6):892. doi: 10.3390/ph18060892.
2
Funding Trends in Japan Agency for Medical Research and Development (AMED): Focus on Psychiatry.日本医疗研究与开发机构（AMED）的资助趋势：聚焦精神医学
JMA J. 2025 Apr 28;8(2):385-394. doi: 10.31662/jmaj.2024-0391. Epub 2025 Apr 4.
3
Evaluating the effectiveness of a multi-component lifestyle therapy program versus psychological therapy for managing mood disorders (HARMON-E): protocol of a randomised non-inferiority trial.评估多组分生活方式治疗方案与心理疗法治疗心境障碍（HARMON-E）的有效性：一项随机非劣效性试验方案。
BMC Psychiatry. 2024 Oct 3;24(1):653. doi: 10.1186/s12888-024-06098-z.
4
Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review.关于艾氯胺酮用于难治性抑郁症治疗的事实与误解：一项叙述性临床综述
Front Psychiatry. 2024 May 15;15:1394787. doi: 10.3389/fpsyt.2024.1394787. eCollection 2024.
5
Combination of Two Long-Acting Antipsychotics in Schizophrenia Spectrum Disorders: A Systematic Review.两种长效抗精神病药物联合用于精神分裂症谱系障碍：一项系统评价
Brain Sci. 2024 Apr 26;14(5):433. doi: 10.3390/brainsci14050433.
6
The social determinants of mental health and disorder: evidence, prevention and recommendations.心理健康与障碍的社会决定因素：证据、预防与建议。
World Psychiatry. 2024 Feb;23(1):58-90. doi: 10.1002/wps.21160.
7
Drug targeting in psychiatric disorders - how to overcome the loss in translation?精神疾病的药物靶向治疗——如何克服转化中的损失？
Nat Rev Drug Discov. 2024 Mar;23(3):218-231. doi: 10.1038/s41573-023-00847-7. Epub 2023 Dec 19.
本文引用的文献
1
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents.精神药理学的未来：对正在进行的2/3期试验以及旨在降低新型药物试验项目风险的一些当前趋势的批判性评估。
World Psychiatry. 2023 Feb;22(1):48-74. doi: 10.1002/wps.21056.
2
A potential biomarker for treatment stratification in psychosis: evaluation of an [F] FDOPA PET imaging approach.精神分裂症治疗分层的潜在生物标志物：[F] FDOPA PET 成像方法的评估。
Neuropsychopharmacology. 2021 May;46(6):1122-1132. doi: 10.1038/s41386-020-00866-7. Epub 2020 Sep 22.
3
Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine.重现精神分裂症的多巴胺病理生理学及其改善方法：氯胺酮的转化成像研究。
Mol Psychiatry. 2021 Jun;26(6):2562-2576. doi: 10.1038/s41380-020-0740-6. Epub 2020 May 7.
4
A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses.迷幻药物在精神疾病治疗中新兴治疗潜力的综述。
J Neurol Sci. 2020 Apr 15;411:116715. doi: 10.1016/j.jns.2020.116715. Epub 2020 Jan 31.
5
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research.难治性精神分裂症的神经生物学：抗精神病药物耐药性的途径及未来研究路线图。
NPJ Schizophr. 2020 Jan 7;6(1):1. doi: 10.1038/s41537-019-0090-z.
6
The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment.双相情感障碍的多巴胺假说：现状及对治疗的启示
Mol Psychiatry. 2017 May;22(5):666-679. doi: 10.1038/mp.2017.16. Epub 2017 Mar 14.
7
Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.与治疗有反应的精神分裂症患者相比，难治性精神分裂症患者前扣带回皮质谷氨酸水平升高。
Schizophr Bull. 2016 May;42(3):744-52. doi: 10.1093/schbul/sbv151. Epub 2015 Dec 17.
8
Diagnosing the decline in pharmaceutical R&D efficiency.诊断制药研发效率下降。
Nat Rev Drug Discov. 2012 Mar 1;11(3):191-200. doi: 10.1038/nrd3681.
Zotero 插件